Observational study on outcomes of primary intracerebral hemorrhage in hospitalized adults
Official title: Clinical Outcomes Following Primary Intracerebral Hemorrhage：A Multicenter Cohort Study
Run by Second Affiliated Hospital, Zhejiang University, School of Medicine · NCT06548737 · Data updated 2026-11-12
This study looks at hospitalized adults with bleeding in the brain to see how common it is, what treatments they get, and how well they do after being treated.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | All |
| Enrollment | 25000 (estimated) |
| Sponsor | Second Affiliated Hospital, Zhejiang University, School of Medicine Academic / other |
| Locations | 1 site (Hangzhou, Zhejiang) |
| Status | Recruiting |
| Started | October 27, 2016 |
| Main results expected | December 31, 2030 |
| Study ends | December 31, 2033 |
| Registry record updated | August 12, 2024 |
| Trial ID | NCT06548737 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are hospitalized adult patients diagnosed with primary intracerebral hemorrhage who meet specific inclusion criteria.
✕Probably not a fit
Patients with intracerebral hemorrhage secondary to known causes or those who had significant disability prior to the current episode may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational cohort study analyzes data from six stroke centers in Zhejiang Province, China, focusing on hospitalized adult patients with primary intracerebral hemorrhage (ICH). The study aims to gather contemporary information regarding the prevalence, characteristics, risk stratification, cost-effectiveness, treatments, and prognosis of these patients. Data is collected by trained registrars using standardized protocols, with oversight from a steering committee to ensure quality and accuracy. Patients included in the study must have undergone specific diagnostic tests upon admission and not received neurosurgical interventions.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the management and outcomes of primary intracerebral hemorrhage, potentially improving patient care and treatment strategies.
How similar studies have gone: Other studies focusing on outcomes of stroke and intracerebral hemorrhage have shown success, indicating that this approach is supported by previous research.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: \- We included adult patients who (1) admitted for primary ICH ; (2) underwent blood routine test (hemoglobin included) and CT scan as soon as they arrived at hospital; (3) were not treated with neurosurgical procedures. Exclusion Criteria: * We excluded patients who (1) had ICH secondary to known causes, including trauma, intracranial neoplasm and systemic diseases12, as well as anticoagulative agents; or had isolated intraventricular hemorrhage (IVH); (2) mRS \>2 before the current ICH episode (according to past medical records or description from guardians.
Where it's running
-
The Second Affiliated Hospital of Zhejiang University
Hangzhou, Zhejiang, China Recruiting
Study contacts
- Study coordinator: Feng Gao, Dr
- Email: 2202012@zju.edu.cn
- Phone: +86-13588451471
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
-
AI-assisted transcranial Doppler ultrasound to detect early brain bleeding
This will try to see if a quick transcranial Doppler ultrasound combined with artificial intelligence can detect intracerebral bleeding in adults with suspected acute stroke within 48 hours of symptom onset.
-
Deep phenotyping to explore recovery in young adults after stroke
This project will test whether a detailed health and sample-collection approach (deep phenotyping) is practical and acceptable for people aged 18–55 who have had a stroke.
-
Stem cell therapy for chronic stroke recovery
This study is testing whether using a patient's own stem cells can help people with long-term stroke recovery feel better and improve their daily functioning.
-
Emergency Stroke Unit for treating acute strokes
This study is testing a new Emergency Stroke Unit that uses a mobile MRI to see if it can help treat stroke patients faster and improve their recovery.
-
Care bundle to improve recovery after intracerebral haemorrhage
This trial will try a structured treatment package—rapid reversal of blood thinners when needed, early intensive blood pressure lowering, and treatment of fever and high blood sugar—to see if it improves 3‑month outcomes for adults with spontaneous intracerebral haemorrhage who arrive within 24 hours of symptom onset.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.